Q32 Bio Inc. QTTB
8.77 USD +0.01 (+0.11%)
Nov 4, 2026, 12:55 PM EST
8.52 Day range 9.17
1.91 52-week range 23.57
- YTD
- +164.16%
- 1 year
- +270.04%
Held by funds
19 US ETFs and mutual funds hold QTTB · largest positions
Ownership
Held by insiders 6.79%
Held by institutions 86.21%
Float held by institutions 92.49%
Institutions 105
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 18.50% | 2,252,987 | 7.28M | Sep 29, 2024 |
| Atlas Venture Life Science Advisors, LLC | 17.18% | 2,092,106 | 6.76M | Sep 29, 2024 |
| Carlyle Group Inc. | 9.05% | 1,102,741 | 3.56M | Sep 29, 2024 |
| FMR, LLC | 3.50% | 426,302 | 1.38M | Sep 29, 2024 |
| Blackrock Inc. | 3.35% | 408,659 | 1.32M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 3.32% | 404,411 | 1.31M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Select Portfolios - Biotechnology | 2.13% | 259,900 | 839.48K | Oct 30, 2024 |
| Fidelity Advisor Biotechnology Fund | 1.66% | 201,678 | 651.42K | Oct 30, 2024 |
| Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 1.56% | 190,000 | 613.70K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.34% | 162,796 | 525.83K | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.28% | 155,361 | 501.82K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.63% | 76,718 | 247.80K | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLOWAY PAUL | President | Conversion of Exercise of derivative security | Mar 24, 2024 | 51,566 |
| BLUM MICHAEL LEE | Officer | Sale | Jan 8, 2023 | 9,408 |
| JORDAN JULIE | Officer | Conversion of Exercise of derivative security | Aug 2, 2023 | 7,496 |
| MICHAUD CHARLES JR. | Officer and Treasurer | Conversion of Exercise of derivative security | Mar 24, 2024 | 18,046 |
| SEYMOUR ALBERT B | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 5, 2023 | 150,874 |
| SMITH W BRADFORD | Chief Financial Officer | Sale | Jan 8, 2023 | 14,219 |